An increase in pro-inflammatory markers was also observed in PBMC-derived monocytes exposed to all glycated forms of HSA, although HSA–CML led to a significantly higher inflammatory response. The gene discussed is ALB; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.